Immix Biopharma Inc. (IMMX)
NASDAQ: IMMX
· Real-Time Price · USD
2.27
0.08 (3.65%)
At close: Sep 05, 2025, 10:04 AM
3.65% (1D)
| Bid | 1.63 |
| Market Cap | 65.6M |
| Revenue (ttm) | 96.29K |
| Net Income (ttm) | -23.13M |
| EPS (ttm) | -0.77 |
| PE Ratio (ttm) | -2.95 |
| Forward PE | -3.04 |
| Analyst | Buy |
| Ask | 2.9 |
| Volume | 25,262 |
| Avg. Volume (20D) | 204,148 |
| Open | 2.20 |
| Previous Close | 2.19 |
| Day's Range | 2.20 - 2.29 |
| 52-Week Range | 1.26 - 3.20 |
| Beta | 0.25 |
About IMMX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMMX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMMX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+15.31%
IMMX stock has given up its prior gain. Immix Biop...
Unlock content with
Pro Subscription
3 months ago
+15.31%
Immix Biopharma shares are trading higher after the company announced the publication of cell therapy NXC-201 Abstract #7508, selected for oral presentation at the 2025 American Society of Clinical Oncology Annual Meeting.
